Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study.
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.
